Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 16/20 | 1.00 |
| ▸ | MMP2 | P08253 | 5/20 | 0.84 |
| ▸ | MMP13 | P45452 | 4/20 | 0.84 |
| ▸ | MMP9 | P14780 | 4/20 | 0.84 |
| ▸ | MMP12 | P39900 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319255 | 0.92 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9MMP12 | |
| SCHEMBL6319765 | 0.90 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9MMP12 | |
| SCHEMBL6319361 | 0.89 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9 | |
| SCHEMBL6325076 | 0.89 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9MMP12 | |
| SCHEMBL6318449 | 0.89 | ADAM17 (0.83) | ADAM17MMP2MMP13MMP9MMP12 | |
| SCHEMBL6322594 | 0.88 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9 | |
| SCHEMBL6319159 | 0.88 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9 | |
| SCHEMBL6325055 | 0.87 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9 | |
| SCHEMBL6318995 | 0.87 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9 | |
| SCHEMBL6322043 | 0.87 | ADAM17 (1.00) | ADAM17MMP2MMP13MMP9MMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6936620-B2 | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases | BRISTOL MYERS SQUIBB COMPANY (US) | 2005-08-30 | — | — | US | claimed |
| EP-1501830-A1 | 7-ARYL-3,9-DIAZABICYCLO[3.3.1]NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | Actelion Pharmaceuticals Ltd. (CH) | 2005-02-02 | — | — | EP | disclosed |
| WO-2003093267-A1 | 7-ARYL-3,9-DIAZABICYCLO(3.3.1)NON-6-ENE DERIVATIVES AND THEIR USE AS RENIN INHIBITORS IN THE TREATMENT OF HYPERTENSION, CARDIOVASCULAR OR RENAL DISEASES | ACTELION PHARMACEUTICALS LTD (CH) | 2003-11-13 | — | — | WO | disclosed |